Skip to content

Carpal Tunnel Syndrome Treated With 830nm Diode Laser

Instiutional Review Board of Chung Shan Medical University Hospital

Status
UNKNOWN
Phases
Phase 1Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00514462
Acronym
CTS
Enrollment
30
Registered
2007-08-10
Start date
2007-07-31
Completion date
2007-08-31
Last updated
2007-08-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Carpal Tunnel Syndrome

Brief summary

The purpose of this study is to determine that 830nm diode laser directly above the transverse carpal ligament (between the pisiform and navicular bone) on subjects' wrists, and test this therapeutic effect.

Detailed description

The low level laser instrument (Painless Light PL-830, Advanced Chips & Products Crop., USA) emitted two light beams with a distance of 2.5cm between them by two laser diodes.

Interventions

DEVICEdiode laser

wavelength at 830nm, 9.7J/cm2 for 10 min

Sponsors

National Taiwan University
CollaboratorOTHER
Chung Shan Medical University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
Yes

Inclusion criteria

* no operation of the wrist * first onset of CTS more than 1 year ago with repeated episodes * never having laser treatment before.

Exclusion criteria

* patients with any rheumatoid arthritis * history of metabolic disease or paralyzed limbs caused by stroke * taking any anti-inflammatory drug * with other treatments, such as acupuncture, physical therapy and wearing orthosis

Design outcomes

Primary

MeasureTime frame
treatment effecttwo weeks

Secondary

MeasureTime frame
EMG, Jamar dynamometer, Carpal tunnel function disability formtwo weeks

Countries

China

Contacts

Primary ContactYu-Chun Yeh, Ph.D
mandy-steven@yahoo.com.tw886922002769

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026